$836 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 92 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 24.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SWAV | SHOCKWAVE MEDICAL | $48,516,000 | +70.6% | 849,811 | 0.0% | 5.80% | +69.6% | |
| FOLD | Sell | AMICUS THERAPEUTICS | $41,491,000 | -10.1% | 3,324,623 | -2.1% | 4.96% | -10.7% |
| APLS | Sell | APELLIS PHARMACEUTICALS | $37,756,000 | +12.1% | 1,489,957 | -13.8% | 4.52% | +11.4% |
| ARRY | Sell | ARRAY BIOPHARMA INC | $36,826,000 | +66.0% | 794,868 | -12.6% | 4.40% | +65.0% |
| TDOC | Sell | TELADOC HEALTH | $34,079,000 | +3.6% | 513,166 | -13.2% | 4.08% | +3.0% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS | $29,216,000 | -20.1% | 402,641 | +3.0% | 3.49% | -20.5% |
| AERI | Buy | AERIE PHARMACEUTICALS | $28,251,000 | -29.2% | 956,036 | +13.8% | 3.38% | -29.6% |
| GILD | Sell | GILEAD SCIENCES INC | $26,892,000 | -5.2% | 398,040 | -8.7% | 3.22% | -5.7% |
| TNDM | Buy | TANDEM DIABETES CARE | $20,638,000 | +139.6% | 319,866 | +135.8% | 2.47% | +138.2% |
| PTCT | Sell | PTC THERAPEUTICS I | $20,279,000 | +16.3% | 450,638 | -2.7% | 2.42% | +15.6% |
| RARX | Sell | RA PHARMACEUTICALS | $20,018,000 | +30.2% | 665,713 | -3.0% | 2.39% | +29.4% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS | $19,576,000 | -7.4% | 721,556 | +18.4% | 2.34% | -7.9% |
| SRPT | Sell | SAREPTA THERAPEUTICS | $17,793,000 | +16.5% | 117,097 | -8.6% | 2.13% | +15.9% |
| NVS | Sell | NOVARTIS AGsponsored adr | $16,677,000 | -15.0% | 182,646 | -10.5% | 1.99% | -15.5% |
| HRC | HILL-ROM HLDS INC | $16,614,000 | -1.2% | 158,799 | 0.0% | 1.99% | -1.7% | |
| PFE | Sell | PFIZER INC | $15,722,000 | -11.7% | 362,927 | -13.4% | 1.88% | -12.2% |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL | $15,449,000 | +9.2% | 1,174,847 | +25.7% | 1.85% | +8.6% |
| LJPC | Sell | LA JOLLA PHARMACEUTICAL | $15,329,000 | +35.5% | 1,657,171 | -5.8% | 1.83% | +34.8% |
| WMGI | Buy | WRIGHT MED GROUP N V | $15,243,000 | -3.3% | 511,173 | +2.0% | 1.82% | -3.9% |
| MRK | Buy | MERCK & CO INC | $13,986,000 | +2.1% | 166,800 | +1.3% | 1.67% | +1.5% |
| FGEN | Buy | FIBROGEN INC | $13,674,000 | +209.6% | 302,660 | +272.5% | 1.64% | +207.9% |
| RCM | Sell | R1 RCM INC | $13,572,000 | +29.1% | 1,078,872 | -0.8% | 1.62% | +28.4% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $13,113,000 | +83.8% | 153,101 | +90.6% | 1.57% | +82.8% |
| AGN | Sell | ALLERGAN PLC | $13,110,000 | +5.5% | 78,300 | -7.8% | 1.57% | +4.9% |
| VCRA | Buy | VOCERA COMMUNICATIONS | $12,181,000 | +0.9% | 381,604 | +0.0% | 1.46% | +0.3% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS | $11,900,000 | -17.7% | 226,241 | -17.2% | 1.42% | -18.2% |
| LLY | Sell | LILLY ELI & CO | $11,817,000 | -18.3% | 106,665 | -4.3% | 1.41% | -18.8% |
| ATRC | Sell | ATRICURE INC | $11,555,000 | +9.7% | 387,224 | -1.5% | 1.38% | +9.1% |
| ASMB | Buy | ASSEMBLY BIOSCIENCES | $11,435,000 | -18.9% | 847,696 | +18.4% | 1.37% | -19.4% |
| XLRN | ACCELERON PHARMA | $11,067,000 | -11.8% | 269,396 | 0.0% | 1.32% | -12.3% | |
| EVH | Buy | EVOLENT HEALTH INC | $10,799,000 | -28.7% | 1,358,352 | +12.8% | 1.29% | -29.1% |
| STML | Buy | STEMLINE THERAPEUTICS | $10,206,000 | +33.3% | 666,158 | +11.8% | 1.22% | +32.5% |
| HMSY | Buy | HMS HOLDINGS CORP | $10,082,000 | +33.8% | 311,278 | +22.3% | 1.21% | +33.0% |
| BMY | Sell | BRISTOL MYERS SQUIBB | $9,737,000 | -6.7% | 214,697 | -1.8% | 1.16% | -7.3% |
| BSX | Sell | BOSTON SCIENTIFIC | $9,738,000 | +4.9% | 226,576 | -6.3% | 1.16% | +4.2% |
| ALXN | New | ALEXION PHARM INC | $9,588,000 | – | 73,199 | +100.0% | 1.15% | – |
| VRAY | Sell | VIEWRAY INC | $9,438,000 | +13.7% | 1,071,265 | -4.6% | 1.13% | +13.1% |
| ALBO | ALBIREO PHARMA INC | $7,834,000 | +0.1% | 242,978 | 0.0% | 0.94% | -0.4% | |
| MDT | Sell | MEDTRONIC PLC | $7,485,000 | -20.9% | 76,851 | -26.1% | 0.90% | -21.4% |
| CI | Buy | CIGNA CORP | $7,454,000 | +13.6% | 47,313 | +15.9% | 0.89% | +12.9% |
| INSP | Buy | INSPIRE MED SYS INC | $7,333,000 | +50.4% | 120,900 | +40.7% | 0.88% | +49.4% |
| OBSV | Buy | OBSEVA SA | $7,274,000 | -9.5% | 643,151 | +2.3% | 0.87% | -10.0% |
| ABT | Sell | ABBOTT LABS | $6,997,000 | -10.3% | 83,198 | -14.8% | 0.84% | -10.8% |
| FTSV | Buy | FORTY SEVEN INC | $6,961,000 | -7.7% | 656,651 | +40.8% | 0.83% | -8.3% |
| VRTX | Buy | VERTEX PHARMACEUTICALS | $6,926,000 | +85.7% | 37,771 | +86.3% | 0.83% | +84.4% |
| IRTC | Buy | IRHYTHM TECHNOLOGIES | $6,848,000 | +10.6% | 86,600 | +4.8% | 0.82% | +9.9% |
| GLYC | Buy | GLYCOMIMETICS INC | $6,589,000 | -3.5% | 552,806 | +0.9% | 0.79% | -4.0% |
| CHNG | New | CHANGE HEALTHCARE IN | $6,578,000 | – | 450,550 | +100.0% | 0.79% | – |
| MGTX | Sell | MEIRAGTX HLDINGS PLC | $6,072,000 | +9.8% | 225,906 | -29.6% | 0.73% | +9.2% |
| EVLO | Buy | EVELO BIOSCIENCES | $6,011,000 | +15.4% | 669,382 | +2.8% | 0.72% | +14.7% |
| ZBH | Buy | ZIMMER BIOMET HLDS | $5,957,000 | -2.2% | 50,598 | +6.1% | 0.71% | -2.9% |
| IMMU | New | IMMUNOMEDICS INC | $5,810,000 | – | 418,900 | +100.0% | 0.70% | – |
| EXAS | EXACT SCIENCES CORP | $4,533,000 | +36.3% | 38,400 | 0.0% | 0.54% | +35.5% | |
| TOCA | New | TOCAGEN INC | $4,476,000 | – | 669,997 | +100.0% | 0.54% | – |
| SAGE | Sell | SAGE THERAPEUTICS | $4,467,000 | -11.1% | 24,400 | -22.8% | 0.53% | -11.7% |
| PODD | Sell | INSULET CORP | $4,317,000 | -50.0% | 36,160 | -60.2% | 0.52% | -50.3% |
| UMRX | UNUM THERAPEUTICS | $4,159,000 | -40.3% | 1,587,437 | 0.0% | 0.50% | -40.7% | |
| AGIO | Buy | AGIOS PHARMACEUTICALS | $3,990,000 | -1.4% | 80,000 | +33.3% | 0.48% | -2.1% |
| Buy | INTEC PHARMA LTD JER | $3,815,000 | -35.7% | 879,000 | +8.7% | 0.46% | -36.0% | |
| MTEM | MOLECULAR TEMPLATES | $2,923,000 | +43.8% | 350,000 | 0.0% | 0.35% | +42.9% | |
| URGN | UROGEN PHARMA LTD | $2,338,000 | -2.7% | 65,063 | 0.0% | 0.28% | -3.1% | |
| PHAS | New | PHASEBIO PHARMACEUTICALS | $2,309,000 | – | 176,000 | +100.0% | 0.28% | – |
| SVRA | Sell | SAVARA INC | $1,756,000 | -73.4% | 741,100 | -17.3% | 0.21% | -73.6% |
| RDY | Buy | DR REDDYS LABS LTDadr | $1,476,000 | +85.0% | 39,397 | +100.0% | 0.18% | +83.3% |
| BGNE | Buy | BEIGENE LIMITEDsponsored adr | $1,392,000 | -3.5% | 11,227 | +2.7% | 0.17% | -4.0% |
| QURE | New | UNIQURE N.V. | $1,133,000 | – | 14,500 | +100.0% | 0.14% | – |
| BPMC | Buy | BLUEPRINT MEDICINES | $1,036,000 | +209.3% | 10,984 | +162.5% | 0.12% | +210.0% |
| SBPH | SPRING BK PHARMACEUTICALS | $1,021,000 | -64.8% | 276,656 | 0.0% | 0.12% | -65.0% | |
| TMO | Sell | THERMO FISHER SCIENTIFIC | $1,013,000 | -18.6% | 3,450 | -24.2% | 0.12% | -19.3% |
| BDX | BECTON DICKINSON | $760,000 | +0.9% | 3,015 | 0.0% | 0.09% | 0.0% | |
| HCM | HUTCHISON CHINA MEsponsored adr | $696,000 | -28.0% | 31,628 | 0.0% | 0.08% | -28.4% | |
| ZLAB | ZAI LAB LTDadr | $439,000 | +18.0% | 12,589 | 0.0% | 0.05% | +15.6% | |
| ABMD | Sell | ABIOMED INC | $424,000 | -93.4% | 1,626 | -92.7% | 0.05% | -93.4% |
| KALV | KALVISTA PHARMACEUTICALS | $389,000 | -22.5% | 17,551 | 0.0% | 0.05% | -21.7% | |
| KURA | KURA ONCOLOGY INC | $232,000 | +18.4% | 11,800 | 0.0% | 0.03% | +16.7% | |
| MYOK | MYOKARDIA INC | $203,000 | -3.8% | 4,051 | 0.0% | 0.02% | -4.0% | |
| ACRX | ACELRX PHARMACEUTICALS | $187,000 | -27.2% | 73,778 | 0.0% | 0.02% | -29.0% | |
| CCXI | CHEMOCENTRYX INC | $166,000 | -32.8% | 17,811 | 0.0% | 0.02% | -33.3% | |
| ATRS | ANTARES PHARMA INC | $156,000 | +9.1% | 47,280 | 0.0% | 0.02% | +11.8% | |
| RVNC | REVANCE THERAPEUTICS | $146,000 | -17.5% | 11,234 | 0.0% | 0.02% | -19.0% | |
| PTGX | PROTAGONIST THERAPEUTICS | $138,000 | -3.5% | 11,400 | 0.0% | 0.02% | 0.0% | |
| CTMX | CYTOMX THERAPEUTICS | $113,000 | +4.6% | 10,058 | 0.0% | 0.01% | +7.7% | |
| MEIP | MEI PHARMA INC | $111,000 | -19.0% | 44,539 | 0.0% | 0.01% | -18.8% | |
| AGLE | AEGLEA BIOTHERAPEUTICS | $89,000 | -14.4% | 12,954 | 0.0% | 0.01% | -15.4% | |
| NABRIVA THERAPEUTICS | $93,000 | 0.0% | 38,255 | 0.0% | 0.01% | 0.0% | ||
| MRNS | MARINUS PHARMACEUTICALS | $70,000 | 0.0% | 16,800 | 0.0% | 0.01% | 0.0% | |
| BLRX | BIOLINERX LTDsponsored ads | $65,000 | -15.6% | 178,297 | 0.0% | 0.01% | -11.1% | |
| ABEO | ABEONA THERAPEUTICS | $61,000 | -34.4% | 12,681 | 0.0% | 0.01% | -36.4% | |
| CRVS | CORVUS PHARMACEUTICALS | $47,000 | -7.8% | 12,594 | 0.0% | 0.01% | 0.0% | |
| CLSD | CLEARSIDE BIOMEDICAL | $25,000 | -30.6% | 25,959 | 0.0% | 0.00% | -25.0% | |
| SRRA | Sell | SIERRA ONCOLOGY INC | $23,000 | -90.4% | 41,076 | -70.7% | 0.00% | -89.7% |
| TTPH | TETRAPHASE PHARMACEUTICALS | $19,000 | -64.2% | 39,821 | 0.0% | 0.00% | -66.7% | |
| CDTX | Exit | CIDARA THERAPEUTICS | $0 | – | -25,447 | -100.0% | -0.01% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -15,582 | -100.0% | -0.02% | – |
| QTNT | Exit | QUOTIENT LTD | $0 | – | -17,649 | -100.0% | -0.02% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -58,013 | -100.0% | -0.02% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL | $0 | – | -3,900 | -100.0% | -0.02% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -4,180 | -100.0% | -0.03% | – |
| UHS | Exit | UNIVERSAL HEALTH SVCcl b | $0 | – | -2,881 | -100.0% | -0.05% | – |
| ONCE | Exit | SPARK THERAPEUTICS | $0 | – | -3,554 | -100.0% | -0.05% | – |
| HUM | Exit | HUMANA INC | $0 | – | -1,841 | -100.0% | -0.06% | – |
| DERM | Exit | DERMIRA INC | $0 | – | -41,902 | -100.0% | -0.07% | – |
| HCA | Exit | HCA HEALTHCARE | $0 | – | -5,316 | -100.0% | -0.08% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -3,361 | -100.0% | -0.12% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -17,799 | -100.0% | -0.30% | – |
| PTI | Exit | PROTEOSTASIS THERA | $0 | – | -2,050,328 | -100.0% | -0.31% | – |
| WCG | Exit | WELLCARE HEALTH PLAN | $0 | – | -16,251 | -100.0% | -0.53% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTI | $0 | – | -42,487 | -100.0% | -0.64% | – |
| ADMS | Exit | ADAMAS PHARMACEUTI | $0 | – | -808,924 | -100.0% | -0.69% | – |
| NITE | Exit | NIGHTSTAR THERAPEUadr | $0 | – | -233,711 | -100.0% | -0.71% | – |
| UNH | Exit | UNITEDHEALTH GRP INC | $0 | – | -34,488 | -100.0% | -1.03% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -179,700 | -100.0% | -2.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.